Pure Extracts Technologies (PULL.C) set their milestone timetable for their study on both the formulation and manufacturing of psilocybin-based treatments today, according to a press… Read More »Pure Extracts Technologies (PULL.C) sets research study milestones for 2021
Pure Extracts Technologies (PULL.C) commenced a study on the formulation and manufacturing of psilocybin-based treatments today, according to a press release. The products will come… Read More »Pure Extracts Technologies (PULL.C) officially joins looming shroom-boom with testing for psilocybin treatments
The notion of magic mushroom market offering after the legalization of cannabis has been floated time and again since long before cannabis legalization was even… Read More »The mushroom market roundup – who to look out for in 2021 featuring TRIP.C, MMED.E, XPHY.C, NUMI.V, and PULL.C
Pure Extracts is targeting the commercial cannabis and psychedelics sector, backed by deep extraction and production expertise.
Pure Extracts Technologies (PULL.C) signed an letter of intent (LOI) with mushroom-derived wellness products company, Nutraceutical Medicine Company, to help springboard Pure’s expansion into the… Read More »Pure Extracts Technologies (PULL.C) latest LOI blends CBD and functional mushrooms
Barely a few weeks after telling the Equity.Guru audience that the timeline on mushrooms would see Pure Extracts (PULL.C) focusing on its core cannabis market,… Read More »Cannabis extractor Pure Extracts (PULL.C) stakes claim in the rocketing mushroom space
Three years in and the cannabis sector is worn out. Most companies are inching along, adding dispensaries and square footage and reporting on it like… Read More »Pure Extracts Technologies (PULL.C) is prepared for coming mushroom market
Yeah, I know, I know. Canadian cannabis companies are ass right now, and have been for a few years. Trust me, I’m about as out… Read More »Pure Extracts (PULL.C) goes public with profit-focused cannabis (and mushroom) extraction business model
